Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piribedil vs Pramipexole/Ropinirole for Vigilance in Parkinson's Disease
NCT01007864Phase 3Completed
- Sponsor
- Desitin Arzneimittel
- Start
- Jan 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of piribedil in Parkinson's disease (PD), sponsored by Desitin Arzneimittel. Started Jan 2010; status: completed.
02
Drugs
piribedil
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01007864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01007864.